We studied the rate of chromosomal cytogenetic abnormalities of fetuses with abnormal sonographic findings detected in the late second or third trimester. Methods: Retrospective analysis of all women at or beyond 23 gestational weeks at a single medical centre, who underwent amniocentesis during January 2012 to December 2015, indicated for abnormal sonographic findings that first appeared and were diagnosed at late second or third trimester. Primary endpoints were the results of fetal karyotype and chromosomal microarray analysis (CMA). Results: 102 women with 103 fetuses underwent amniocentesis due to late onset abnormal sonographic findings. All fetuses had a normal karyotype. Ninety-five women also had CMA performed. The detection rate of abnormal CMA (5/95, 5.3%) was similar to that of women who underwent amniocentesis due to abnormal early onset ultrasound findings detected at routine prenatal screening tests during the 1st or early 2nd trimester (7.3%, p=.46) and significantly higher than that for women who performed amniocentesis and CMA upon request, without having any fetal abnormal sonographic findings or medical indication for CMA (0.99%, p<.0001). Conclusions: Late onset sonographic findings are an indication for amniocentesis. We suggest that if amniocentesis is performed, CMA should be applied to evaluate fetuses with late onset abnormal sonographic findings.
Objectives:
To assess the value of genetic testing and morphological examination in a cohort of patients with gastroschisis. Methods: A single centre cohort study was performed, including cases with gastroschisis born between 1982-2002, and their parents. Structural clinical examination directed to morphologic anomalies was performed and compared to a validated control group. Array was used to identify copy number variants (CNVs). CNVs were compared to previously reported patients with gastroschisis and healthy controls derived from the local and publicly available databases. In cases with intellectual disability whole exome sequencing (WES) was performed. Results: Twenty-one cases were included (median age 11, range 4-27 years). Cases had a significant increase of ≥ 2 minor abnormalities compared to controls (89.5 % versus 55.7% P=0.004). The occurrence of ≥ 1 major anomaly was not significant increased compared to controls. Seven inherited and one de novo CNVs were detected in five cases. No overlap with the CNVs region was found between cases of this study or gastroschisis cases described in literature or databases. Two cases had intellectual disability. WES detected a pathogenic de novo mutation in the MECP2 gene in one case and a single nucleotide variant, variant of uncertain significance, (VUS) in the KCNQ2 gene in the second case. Conclusions: In a cohort of 21 gastroschisis cases, we detected significantly more minor morphological anomalies, one de novo CNV and one, possibly two, monogenetic disorders. Pediatric follow-up, syndrome diagnosis and genetic analysis are indicated in children with gastroschisis, especially when additional anomalies and/or intellectual disability present.
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The prenatal diagnosis of volvulus in a fetus with congenital diarrhoea (CD) probably associated with a GUCY2C gene variant 
